关于大脑动脉静脉瘤发病的最新研究及其治疗点
1Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, Japan.
Journal of neuroendovascular therapy
|February 17, 2025
概括
本综述探讨了脑动脉静脉形形 (bAVMs) 背后的分子和遗传因素,旨在澄清它们的发病因子,以获得更好的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 血管生物学 血管生物学
背景情况:
- 大脑动脉静脉形形 (bAVMs) 存在大脑内出血和严重患者并发症的重大风险.
- 虽然已经研究了遗传性bAVM,但它们的基本病原性仍然不完全理解.
研究的目的:
- 审查目前关于bAVM分子和遗传基础的数据.
- 阐明微血管架构,血管生成因子和信号通路在bAVM发育中的作用.
- 为了解零星和遗传bAVM病原体提供见解.
主要方法:
- 对bAVM分子和遗传方面的最新研究进行了全面的文献综述.
- 分析有关微血管,血管生成和信号通路的数据.
- 综合信息以确定关键的致病机制.
主要成果:
- 关于导致bAVMs的分子和遗传因素的最新数据.
- 了解bAVM微血管结构的结构和功能特征.
- 确定关键的血管生成因子和涉及的信号通路.
结论:
- 了解bAVM的分子和遗传基础对于管理出血风险至关重要.
- 这一综述巩固了当前的知识,促进了对bAVM病原学的更深入理解.
- 这些发现可以指导针对bAVM的向预防性治疗的开发.
更多相关视频
14:58Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
9.6K
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
1.9K
相关概念视频
The Blood-brain Barrier
Overview
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
